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Background: Exome sequencing is increasingly used to search for phenotypically-relevant sequence variants in the
mouse genome. All of the current hybridization-based mouse exome capture systems are designed based on the
genome reference sequences of the C57BL/6 J strain. Given that the substantial sequence divergence exists
between C57BL/6 J and other distantly-related strains, the impact of sequence divergence on the efficiency of such
capture systems needs to be systematically evaluated before they can be widely applied to the study of those
strains.
Results: Using the Agilent SureSelect mouse exome capture system, we performed exome sequencing on F1
generation hybrid mice that were derived by crossing two divergent strains, C57BL/6 J and SPRET/EiJ. Our results
showed that the C57BL/6 J-based probes captured the sequences derived from C57BL/6 J alleles more efficiently
and that the bias was higher for the target regions with greater sequence divergence. At low sequencing depths,
the bias also affected the efficiency of variant detection. However, the effects became negligible when sufficient
sequencing depth was achieved.
Conclusion: Sufficient sequence depth needs to be planned to match the sequence divergence between
C57BL/6 J and the strain to be studied, when the C57BL/6 J–based Agilent SureSelect exome capture system is to
be used.
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Massive parallel sequencing has revolutionized the search
for sequence variants in the human genome as well as
other model organisms. Compared with the Sanger
method, these so-called next-generation sequencing
platforms can sequence DNA much faster and at a
much lower cost [1,2]. The resequencing of an entire
human genome can now be achieved within days at the
cost of a few thousand dollars. In spite of such dramat-
ically improved performance, the current technology
does not allow routine screening of the complete genome
for a large number of samples in an economically-efficient
manner [3]. Even when the cost of whole genome
sequencing breaks the much-anticipated $1000 threshold,
the necessary computational workload could still remain* Correspondence: wei.chen@mdc-berlin.de
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reproduction in any medium, provided the orburdensome and limit its widespread implementation
outside major genome centres. In comparison, targeted
sequencing is less expensive and generates datasets several
orders of magnitude smaller [4-8]. In recent years, exome
sequencing (i.e. the sequencing of the full complement
of protein-coding exons in the genome) has therefore
become a favoured approach in identifying sequence
variants causing rare as well as common human diseases
[9-11].
Over the last few decades, the mouse has emerged as
a preeminent model organism for exploring human
biology. Since over 90% of known mouse genes have an
orthologue in the human genome, identification of genetic
defects responsible for certain phenotypes in mice can
directly indicate the genes involved in human diseases.
Recently, given the success of exome sequencing in identi-
fying human disease-causing variants, hybridization-based
exome capture systems have been developed for mouse
and are now commercially available [12,13]. The current
design of mouse exome capture probes is based on the. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the robustness of applying such systems in other strains
has been shown in a study that mapped putative N-ethyl-
N-nitrosourea (ENU)-induced mutations in four different
inbred Mus musculus strains [12]. However, the marginal
differences between the genomes of C57BL/6 J and the
other strains used in that study do not allow for a system-
atic evaluation of the effects of sequence divergence on
the efficiency of sequence capture and variant detection.
In addition, the effect of sequence divergence could be
even greater in a mixed genetic background.
The genome of the SPRET/EiJ strain has recently
been sequenced. Compared with that of C57BL/6 J, the
genome of SPRET/EiJ contains about 35.4 million single
nucleotide variants (SNVs) and 4.5 million insertion
and deletions (indels) [14]. In this study, to gain a better
understanding of how sequence divergence could affect
the efficiency of the current exome capture system, es-
pecially in a mixed genetic background, we performed
exome sequencing in a F1 hybrid mouse generated by
crossing the two strains with a high degree of sequence
variation. After mapping the sequencing reads separately
to the genomes of the two parental strains, we observed
that probes captured the sequences derived from C57BL/
6 J alleles more efficiently and the bias was higher for
target regions with greater sequence divergence. Such
bias also reduced the efficiency of variant detection which
could be counteracted by higher sequencing depth.
Results and discussion
Exome capture
To evaluate whether sequence divergence could affect
exome capture, especially in a mixed genetic background,
we performed exome sequencing on a F1 hybrid mouse
derived from crossing C57BL/6 J and SPRET/EiJ mice
using an Agilent SureSelect XT Mouse All Exon Kit
(Methods). With a design based on the genome sequences
of C57BL/6 J strain (UCSC genome browser mm9), the kit
contains 565,918 probes of length 120 nucleotides (nt)
that are targeted at the exonic regions of 24,306 genes.
Among all the target regions, we could unambiguously
identify orthologous regions in the SPRET/EiJ genome for
404,992 targets (Methods). To control for complicating
factors beyond exome capture bias, we simulated three
exome sequencing datasets without any allelic bias in
capture efficiency (Methods). Furthermore, we performed
whole genome sequencing (WGS) on the same F1
hybrid mouse. Only the 396,870 targets that did not
show significant allelic bias in sequencing depth from
either simulation or WGS were retained for further ana-
lysis (Methods, Additional files 1 and 2). Among these
targets the sequences of 136,956 targets are identical
between the two strains, whereas the remaining 259,914
targets contain up to 15 SNVs and 10 indels (Figure 1).In total, we performed three replicate exome capture
experiments, each of which being then sequenced for
single-end 101 nt on one single lane of the Illumina
HiSeq 2000 flowcell. An average of 196.9 million reads
was generated from each replicate, among which 85.5%
could be mapped to the genome of either strain (Table 1).
Between 51.8 and 53.4 million non-redundant reads
mapped to the 396,870 target regions were used to
assess the allelic bias in capture efficiency (Table 1).
More specifically, for each of these targets, we calculated
the number of reads that could be mapped only to the
C57BL/6 J or SPRET/EiJ genome. As shown in Table 1
and Figure 2A, the reads mapped only to C57BL/J alleles
were clearly overrepresented. The fact that such bias
did not exist in the simulation or WGS data indicated
the probes captured the target sequences derived from
C57BL/J allele more efficiently (Table 1 and Figure 2B, C).
Assuming that the allelic capture bias observed above
was largely due to the sequence divergence between the
two strains, we assessed the impact of sequence diver-
gence in greater detail. Here we checked the effect of
SNVs and indels, separately. In total, 365,369 targets
containing no indels between the two strains were
grouped based on the number of SNVs. As shown in
Figure 3A, compared with those targets with identical
sequences, the targets containing SNVs showed signifi-
cant capture biases toward C57BL/J. The more SNVs
the targets contained, the higher the bias was observed
(Figure 3A). Interestingly, the distribution of multiple
SNVs within the target regions also had an impact on
the capture bias (Additional file 3). Furthermore, a clear
effect on allelic bias could also be seen for indels by com-
paring the targets containing indels to those containing
the same number of SNVs, but no indels (Figure 3A).
Notably, such biases did not exist in simulation or WGS
data (Figure 3B, C).
Variant detection
We next sought to check whether the capture bias
would affect the efficiency of variant detection. For this
purpose, we mapped the exome sequencing reads only
to the C57BL/6 J genome and aimed to identify the
heterozygous variants derived from the SPRET/EiJ allele.
Using our mapping procedure, the sequencing reads
derived from SPRET/EiJ allele containing >5 SNVs and
indels could not be mapped on the C57BL/6 J genome.
Since we focused on the effect of capture bias, we first
needed to filter out the target regions that could be
potentially affected by such mapping bias. To identify
these specific regions, we mapped the simulated exome
sequencing reads to either both genomes together or to
only the C57BL/6 J genome. The numbers of sequencing
reads that could be mapped using these two strategies
were then compared for each of the 396,870 targets.
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Figure 1 Histograms of the targets with different levels of sequence divergence. The 396,870 targets that were used for evaluating capture
efficiency were grouped based on the number of SNVs (A) or indels (B) between the C57BL/6 J and SPRET/EiJ genomes. The numbers of targets
(Y axis) with different numbers of SNVs (X axis) or indels (X axis) were shown.
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mapped based on the ‘two genome approach’. To exclude
the effect of mapping bias, we retained only the 241,729
targets on which the number of reads mapped using
the two mapping strategies was the same in all the
three simulated datasets. In total, there were 192,614
SNVs and 5511 indels falling within these targets and
the distribution of the number of SNVs and indels
across these targets were shown in Figure 4.
We called variants within these targets based on the
three exome sequencing datasets (Methods). Given the
relatively limited performance of current variant callers
on the indel identification, we focused our analysis onTable 1 Summary of mapping results from exome sequencing
Exome 1
(million)
Exome 2
(million)
No. of total reads 201.4 195.1
No. of reads uniquely mapped to either
genome
171.9 167.0
No. of non-redundant reads mapped to the
targets on either genome
53.4 52.4
No. of non-redundant reads mapped only to
the targets from C57BL/6 J
19.0 18.7
No. of non-redundant reads mapped only to
the targets from SPRET/EiJ
17.4 17.0SNVs. As shown in Figure 5, 194,929 SNVs were identi-
fied in all the three replicates, whereas 1202 and 772
were only found in two and one replicates, respectively.
Of the 192,614 SNVs present in the SPRET/EiJ genome
reference sequences, 99.4%, 99.8% and 99.9% could be
identified in at least three, two and one replicates, re-
spectively. A total of 4505 SNVs identified in at least one
replicates were not found in the SPRET/EiJ genome
reference sequences. These variants could represent false
positive findings. However, 3559 and 436 of them could
be detected in three and two replicates, respectively,
implicating that they might be true variants but absent
in the reference sequences. Indeed, 3092 were annotated, WGS and simulated exome sequencing
Exome 3
(million)
WGS
(million)
Simulation1
(million)
Simulation2
(million)
Simulation3
(million)
194.2 1097.0 75.0 75.0 75.0
166.1 921.1 74.9 74.9 74.9
51.8 21.3 58.8 58.8 58.8
18.5 7.1 20.0 20.0 20.0
16.9 7.1 20.0 20.0 20.0
Figure 2 Evaluation of allelic bias in capture efficiency. MA plots comparing the number of sequencing reads that overlapped with a target
derived from C57BL/6 J with that from SPRET/EiJ allele based on exome sequencing (A), simulated data (B) or WGS (C). The sum of the number
of sequencing reads that could be mapped only to either genome was plotted on the X axis, and the log2 transformed ratio between the
number of reads derived from C57BL/6 J and that from SPRET/EiJ allele was on the Y axis. The numbers of targets with log2 transformed
ratio > =0.5 or < = −0.5 were shown in the respective figure. In exome sequencing, the reads mapped only to C57BL/J were clearly
overrepresented whereas such bias did not exist in the simulated or WGS data.
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ac.uk/resources/mouse/genomes/) [14] and 3618 could
also be detected using our WGS data.
We achieved an average sequencing depth of 91.1 for
all nucleotide positions within the 241,729 targets using
one lane of a single flowcell. 98% and 100% of all the
positions were covered by more than 20 and 5 sequencing
reads, respectively. Of note, such a sequencing depth was
sufficiently high to discover most (99.7%) of the variants
even though the exome capture was biased against variant
carrying alleles. Therefore, we then addressed how the
variant detection would work at lower sequencing depth
and whether the exome capture bias could then have an
effect on variant detection. We randomly sampled a subset
of reads from the first exome sequencing replicate to cover
the targets at an average sequencing depth of 10, 20, 30,
40, 50, 60, 70 and 80, respectively. As expected, the sensi-
tivity decreased with the reduced sequencing depth. We
then grouped the targets based on the number of SNVs
they contained. As shown in Figure 6A, at a lower sequen-
cing depth, the sensitivity was lower for the targets
containing more SNVs. For example, at average depth
of 10, whereas a sensitivity of 76.7% was achieved for
the targets containing only one SNV, the sensitivity for
the targets with four SNVs dropped to 71.2%. A similar
trend was not observed for simulated data, implicating
the decreased sensitivity was largely due to capture bias
(Figure 6B).
In this study, on one hand, to avoid the effect of map-
ping bias, we focused our analysis only on the targets
containing no more than 6 SNVs and 4 indels. As shown
in the previous section, the greater the sequence diver-
gence, the higher capture bias was observed. Thereforeit is conceivable that the efficiency in variant detection
could be even lower for the targets with higher sequen-
cing divergence. On the other hand, we used the capture
system to detect heterozygous variants in a F1 hybrid
mouse. For many research projects that work on pure
inbred strains and/or only search for homozygous vari-
ants, the effect of sequence divergence might be more
subtle than what has been demonstrated here.
Conclusions
With the enormous progress in the field of human genet-
ics, exome capture systems have been developed to search
for phenotypically-relevant mutations in mice. Unlike
the human genome in which sequence differences among
individuals are rather limited, the sequence divergence
between different mouse strains could be substantial.
However, it had not been extensively explored whether
the sequence divergence could affect the efficiency of
hybridization-based capture systems designed based on
a reference genome (C57BL/6 J) when applied in the study
of distantly-related strains. In this study, we performed
an exome capture and sequencing on a F1 hybrid mouse
generated by crossing the C57BL/6 J and SPRET/EiJ
strains. Our results clearly demonstrated that the probes
captured the sequences derived from C57BL/6 J alleles
more efficiently and the bias increased for the target
regions with higher sequence divergence. This bias also
affected the efficiency of variant detection. The effect,
however, could be counteracted by increasing sequencing
depth. For example, to achieve a 99% detection sensitivity,
an average sequencing depth of 50 or 60 would be re-
quired for the regions containing one or four SNVs.
Therefore, in the design of exome sequencing in different
Figure 3 (See legend on next page.)
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Figure 3 Effects of sequence divergence on capture bias. Boxplots showed the distribution of capture bias (i.e. log2 transformed ratio
between the number of reads derived from C57BL/6 J and that from SPRET/EiJ allele) for the targets without indels grouped by the number of
SNVs (white boxes) based on exome sequencing (A), simulated exome sequencing data (B) or WGS (C). In exome sequencing, compared with
the targets with identical sequence between the two genomes, the targets containing SNVs showed significantly higher capture biases toward
C57BL/J. The more SNVs the targets contained, the higher the bias was observed. Compared with the targets containing no indels (white boxes),
those containing the same number of SNVs, but also indels (grey boxes), showed significantly higher capture biases toward C57BL/J. Both biases
were not observed in simulated and WGS data. * denotes statistically significant differences (P < 0.01).
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need to be planned to match the sequence divergence
between the strain and C57BL/6 J.
Methods
Exome capture and sequencing
Whole exome sequencing libraries were prepared using
an Agilent SureSelect XT Mouse All exon kit. Genomic
DNA samples extracted from mouse (a female F1 hybrid
mouse derived from crossing C57BL/6 J and SPRET/EiJ)
liver were used to generate Illumina Paired-End pre-
capture libraries according to the manufacturer’s protocol
(Agilent). After determining concentration and quality,
3 μg genomic DNA was sheared into fragments with an
average length between 150 and 200 bp using a Covaris S2
system (Covaris). The fragmented DNA was end-repaired0 1 2 3 4 >4
No. SNV
Fr
eq
ue
nc
y
0
20
00
0
40
00
0
60
00
0
80
00
0
10
00
00
A
Figure 4 Histograms of the targets with different sequence divergenc
evaluating the efficiency of variant detection were grouped based on the n
genomes. The numbers of targets (Y axis) with different numbers of SNVs (in 100 μl total reaction volume containing 48 μl sheared
DNA, 10 μl 10X buffer, 1.6 μl dNTP, 1 μl T4 DNA poly-
merase, 2 μl Klenow DNA polymerase and 2.2 μl T4 Poly-
nucleotide Kinase at 20°C for 30 minutes. A-tailing was
performed in a total reaction volume of 50 μl containing
end-repaired DNA, 5 μl 10X buffer, 3 μl Klenow Frag-
ment, 1 μl dATP and 11 μl water at 37°C for 30 minutes.
Illumina adapter ligation was performed in a total reaction
volume of 50 μl containing 10 μl 5X buffer, 10 μl ligase
and 10 μl adaptor oligo mix at room temperature for
30 minutes. After ligation, PCR with Illumina PE 1.0 and
SureSelect GA Indexing Pre Capture PCR Reverse Primer
was performed in 50 μl reactions containing 10 μl 5x
Herculase II Rxn Buffer, adaptor-ligated DNA, 1.25 μl of
each primer, 0.5 μl 100 mM dNTP mix and 1 μl Herculase
II Fusion DNA Polymerase. The standard thermocycling0 1 2 >2
No. Indel
Fr
eq
ue
nc
y
0
50
00
0
10
00
00
15
00
00
20
00
00
25
00
00
B
e. The 241,729 targets without mapping biases that were used for
umber of SNVs (A) or indels (B) between the C57BL/6 J and SPRET/EiJ
X axis) or indels (X axis) were shown.
191370
279
2573559
230
150 98
167 91
169
164 177
216
73
119
Replicate1
Replicate2 Replicate3
SPRET genome
Figure 5 Number of SNVs detected by the three exome
sequencing replicate experiments. In total, 194,929 SNVs were
identified in all the three replicates, whereas 1202 and 772 were
found in two and one replicates, respectively. Of the 192,614 SNVs
present in the SPRET/EiJ genome reference sequences, 99.4%, 99.8%
and 99.9% could be identified in at least three, two and one
replicates, respectively. A total of 4505 SNVs identified in at least one
replicates were not found in the SPRET/EiJ genome reference
sequences. 3559 and 436 of them could be detected in three and
two replicates, respectively.
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followed by 6 cycles of 30 seconds at 98°C, 30 seconds at
65°C and 60 seconds at 72°C and a final extension for
10 minutes at 72°C. Agencourt® XP® Beads (Beckman
Coulter Genomics) was used to purify DNA after each
enzymatic reaction. After bead purification, the amount
and size of PCR products were determined using an
Agilent 2100 Bioanalyzer (Agilent) and Qubit (Life
Technology).
Then, 500 ng of Illumina paired-end pre-capture li-
brary DNA was hybridized to Agilent SureSelect mouse
exome capture probes according to the manufacturer’s
specifications. After assessing the quality of capture
libraries using Agilent 2100 Bioanalyzer, the captured
library was sequenced using Illumina HiSeq 2000 system
according to the manufacturer’s protocol. Each library
was sequenced in a separate lane in a 101 nt single-end
sequencing format.
Whole genome sequencing (WGS)
An Illumina paired-end sequencing library was gener-
ated from the same genomic DNA used for exome se-
quencing (see above) according to the manufacturer’s
protocol (Illumina). The procedure is the same as the
one for constructing the precapture library described
above. The library was sequenced in seven lanes in a 2 x
100 nt paired-end sequencing format using Illumina
HiSeq 2000 system according to manufacturer’s protocol.
In this study, to be comparable with the format of exome
sequencing, we analyzed only the first reads from WGS.Mapping orthologous target regions in the
SPRET/EiJ genome
The Agilent SureSelect XT Mouse All Exon Kit was
designed based on the C57BL/6 J genome (UCSC mm9).
The BED file containing all the target regions on the
C57BL/6 J genome was downloaded from the Agilent
website (www.genomics.agilent.com). The C57BL/6 J se-
quences of all the targets except those from chrY and
mitochondrial were downloaded from UCSC genome
browser (mm9). The SPRET/EiJ genome sequences were
downloaded from the Sanger Institute (http://www.sanger.
ac.uk/resources/mouse/genomes/). The C57BL/6 J sequen-
ces were then aligned to the SPRET/EiJ genome using
the BLAST tool with default parameters [15]. Only the
targets that could be uniquely mapped in the same
chromosome as in the C57BL/6 J genome were retained.
In addition, we excluded the targets that did not lie in the
same 5’-to-3’ order with their neighbouring targets as in
the C57BL/6 J genome. Each of the remaining targets was
then extended 100 nt from both 5’ and 3’ ends. Those
targets that were extended into the regions without
reference sequences (shown as ‘N’s in the genome ref-
erence sequences) in either genome were discarded.
Simulation of exome sequencing
We simulated the exome sequencing datasets by ran-
domly extracting 75 million single-end 101nt sequencing
reads from the 404,992 target regions on both the
C57BL/6 J and SPRET/EiJ genomes. These targets re-
gions were selected to have an unambiguous one-to-one
orthologue between the two strains as described above.
In total, we repeated the simulation three times and each
simulation was performed as following:
1) Randomly select one target i. Here the target from
the C57BL/6 J and SPRET/EiJ genomes was treated
as different ones. The probability of choosing a
target i was its length divided by the cumulative
length of all the 809,984 (2 * 404,992) targets.
2) Randomly select a start position j of a sequencing
read within the target i. Here each of the
positions between (istart − 100) and iend (istart, the
start position of target i; iend, the end position of
target i ) was chosen with equal probability. The
end position of the sequencing read was then
j + 100.
3) Randomly select the strand. Here forward or
reverse strand was chosen with equal probability
4) Extract the sequence of the read from either
C57BL/6 J or SPRET/EiJ genome according to 2)
and 3). The quality scores for all the bases were
set to be 40 (the maximum in the Sanger scale);
5) Repeat step 1 to step 4 for 75 million times to
generate 75 million sequencing reads.
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Figure 6 The sensitivity of variant detection at lower sequencing depths for the targets containing different SNVs. The sensitivity of
variant detection (Y axis) was plotted for the targets containing different number of SNVs (different lines) at different average sequencing depths
(X axis) based on exome sequencing (A) or simulated data (B). In exome sequencing, the sensitivity of variant detection became decreased with
the reduced sequencing depths. At lower sequencing depths, the sensitivity was lower for the targets containing more SNVs. For example, at
average depth of 10, whereas a sensitivity of 76.7% was achieved for the targets containing only one SNV, the sensitivity for the targets with four
SNVs dropped to 71.2%. Such a trend was not observed for simulated data, implicating the decreased sensitivity was largely due to capture bias.
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Raw sequencing reads in FASTQ format from either
exome sequencing, WGS, or simulated datasets, were
aligned separately to both C57BL/6 J and SPRET/EiJ
genomes with the Burrows-Wheeler Aligner (BWA)
(Additional file 4) [16]. Reads that could be mapped
to multiple positions in one or both genomes were dis-
carded. Reads that could be mapped to both genomes
with the same edit distance were also excluded for
the analysis of allelic bias in capture efficiency since
their allelic origins could not be determined. PCR
duplicates were removed with Picard MarkDuplicates
(http://picard.sourceforge.net) (Additional file 4). Of the
remaining reads, if a read could be mapped only to one
genome, the allelic origin is obvious, while if a read
could be mapped to both genomes with different edit
distances, the strain with smaller edit distance was
assigned as the allelic origin. To evaluate allelic bias in
capture efficiency, for each of the target, the number of
sequencing reads that were overlapped with the targeton C57BL/6 J genome was compared to the number of
overlapping sequencing reads derived from SPRET/EiJ
genome. The sequencing depth of each nucleotide pos-
ition was designated as the number of sequencing reads
overlapped with that position. The sequencing depth of
a target region was calculated as the mean depth of all
nucleotide positions within the target.
Variant detection
Raw sequencing reads from exome sequencing, WGS or
simulation were aligned to the C57BL/6 J genome using
BWA with the same parameters as described in “Evalu-
ation of allelic bias in capture efficiency”. PCR duplicates
were removed with Picard MarkDuplicates with the
same parameters as described in “Evaluation of allelic
bias in capture efficiency”. The Genome Analysis Toolkit
(GATK) variant calling pipeline (version 2.2.15) was
then used to identity SNVs on each data set separately
[17]. In brief, the RealignerTargetCreator and the
IndelRealigner tools were used for local realignment
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tools were used for quality score recalibration, the
UnifiedGenotyper tool was used for variant calling, and
the VariantRecalibrator and ApplyRecalibration tools were
used for variant quality score recalibration. All the
commands were listed in Additional file 4.
Animal ethics statement
Mice were housed and maintained in a temperature-
controlled, 12-hour light/dark cycle environment with
ad libitum access to regular chow food in accordance to
requirements established by Landesamt für Gesundheit
und Soziales (Lageso). All experimental procedures were
approved under protocol T 0436/08.
Availability of supporting data
The data sets supporting the results of this article are
available in the European Nucleotide Archive (accession
number ERP002193).
Additional files
Additional file 1: Exclusion of targets with other complicating
factors based on simulated data. (A-C) MA plots comparing the
number of sequencing reads that overlapped with a target derived
from C57BL/6 J with that from SPRET/EiJ allele based on three
simulated exome sequencing data. The sum of the number of
sequencing reads that could be mapped only to either genome was
plotted on the X axis, and the log2 transformed ratio between the
number of reads derived from C57BL/6 J and that from SPRET/EiJ allele
was on the Y axis. The red dots represent outlier targets, i.e. their log2
ratio falling outside the 0.5% ~ 99.5% quantiles. (D) The overlap of
outlier targets identified in the three replicate simulations. The 780
targets identified as outliers in at least two replicates (shown in red)
were discarded in subsequent analysis.
Additional file 2: Exclusion of targets with other complicating
factors based on WGS data. MA plot comparing the number of
sequencing reads that overlapped with a target derived from C57BL/6 J
with that from SPRET/EiJ allele based on WGS data. The sum of the
number of sequencing reads that could be mapped only to either
genome was plotted on the X axis, and the log2 transformed ratio
between the number of reads derived from C57BL/6 J and that from
SPRET/EiJ allele was on the Y axis. The red dots represent outlier
targets, i.e. their log2 ratio falling outside the 0.5% ~ 99.5% quantiles or
the sum of the number of sequencing reads being more than 110. All
the 7525 outliers were discarded in subsequent analysis.
Additional file 3: Impact of distribution of multiple SNVs in the
target regions on the capture bias. To check whether the SNVs
distribution within the target regions could affect the capture
efficiency, we focused on the 64,470 targets containing two SNVs, but
no indels and grouped them by the distance between the two SNVs.
The distance between the two SNVs was shown on the X axis, and the
log2 transformed ratio between the number of reads derived from
C57BL/6 J and that from SPRET/EiJ allele was on the Y axis. Compared
with the targets with two SNVs being far away, those with the two
SNVs being right next to each other displayed higher biases in the
capture efficiency. * denotes statistically significant differences.
Additional file 4: List of data analysis commands.
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